The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K.
Radar 81 (high attention) · dilution pressure high · listing risk low · governance risk elevated · runway 12.5 mo · strongest signal: New going-concern flag (Aug 14, 2026)
What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.
The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (new going-concern flag, negative equity) coexists with live selling machinery (convertible note). Base case is a discounted raise; the question is when, not if.
No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
| Date | Signal | Evidence | Score |
|---|---|---|---|
| Aug 14, 2026 | ▼ New going-concern flag | “going concern periodic” language in 10-Q (10-Q) filed 2026-08-14 filing | 68 |
| Aug 4, 2026 | ▼ Convertible note | “convertible note” language in 8-K (EX-99.1) filed 2026-08-04 filing | 42 |
| Aug 4, 2026 | ▼ Unregistered sale | 8-K Item 3.02 filed 2026-08-04 (accepted 07:50 ET) filing | 41 |
| Aug 4, 2026 | · 13D amendment | Schedule 13D/A filed 2026-08-04 filing | 24 |
| Jun 30, 2026 | ▼ Share count +25% | Shares outstanding 65,856,898 (2026-05-08) -> 100,849,644 (2026-08-06), +53% filing | 35 |
| Jun 30, 2026 | ▼ Negative equity | Stockholders' equity $-138,575,000 as of 2026-06-30 filing | 31 |
| Jun 30, 2026 | ▼ Cash < current liabilities | Liquidity $13,269,000 vs current liabilities $151,619,000 filing | 21 |
VIVS VivoSim Labs, INC. · HCWB HCW Biologics Inc. · CYCU Cycurion, Inc. · BIAF bioAffinity Technologies, In · XHLD TEN Holdings, Inc. · VSEE VSEE HEALTH, INC. · screener →